TL;DR — Creatine and Brain Imaging
Modern neuroimaging — particularly magnetic resonance spectroscopy (MRS) — allows scientists to measure creatine and phosphocreatine levels in the living brain non-invasively.
MRS studies have confirmed that oral creatine supplementation increases brain creatine concentrations by approximately 5-10%, and that certain populations (vegetarians, elderly, those with neurological conditions) have lower baseline brain creatine levels.
Intriguingly, total creatine has long been used as a “stable reference” in MRS studies — but research now shows this assumption may be flawed, as brain creatine levels vary with diet, supplementation, age, and disease.
Brain imaging studies provide the critical mechanistic link between oral creatine supplementation and the cognitive improvements observed in clinical trials.
What Is Magnetic Resonance Spectroscopy?
Magnetic resonance spectroscopy (MRS) is a non-invasive neuroimaging technique that measures the concentration of specific metabolites in the brain.
While standard MRI provides structural images (showing brain anatomy), MRS provides chemical information — it reveals the concentrations of molecules like creatine, phosphocreatine, N-acetylaspartate (NAA), choline, glutamate, and lactate in specific brain regions.
MRS works by detecting the unique magnetic resonance signatures of hydrogen atoms (protons) in different chemical environments.
Each metabolite produces a characteristic spectral peak at a specific frequency, allowing quantification of its concentration.
For creatine research, MRS is the gold-standard technique for measuring brain creatine and phosphocreatine levels in living humans.
Phosphorus-31 MRS (31P-MRS) provides even more specific information about the brain’s energy status by directly measuring PCr and ATP concentrations, as well as the PCr/ATP ratio — a direct indicator of the brain’s energy reserve.
MRS Evidence for Creatine Supplementation
Brain Creatine Increases with Supplementation
Multiple MRS studies have demonstrated that oral creatine supplementation increases brain creatine and phosphocreatine levels.
The typical increase is in the range of 5-10% — smaller than the 20-40% increase seen in skeletal muscle, but physiologically significant.
The smaller increase in the brain compared to muscle reflects the blood-brain barrier’s regulation of creatine transport.
The brain’s creatine transporter (SLC6A8) actively transports creatine across the BBB, but the rate is limited.
This is why brain creatine saturation takes longer than muscle saturation and why consistent, sustained supplementation is important for cognitive benefits.
Roschel et al. (2021) reviewed the neuroimaging evidence as part of their broad assessment of creatine’s effects on brain health (Roschel et al., 2021) .
Population Differences in Brain Creatine
MRS studies have revealed important differences in brain creatine levels across populations:
Vegetarians and vegans show lower brain creatine levels compared to omnivores, reflecting the absence of dietary creatine from meat and fish.
This finding aligns with the cognitive benefits observed by Rae et al. (2003), who showed the greatest improvements in vegetarian participants (Rae et al., 2003) .
Elderly individuals tend to have lower brain creatine and phosphocreatine levels compared to younger adults, consistent with age-related declines in brain energy metabolism.
Patients with neurological conditions — including depression, TBI, and neurodegenerative diseases — often show reduced brain creatine levels in affected regions, suggesting a link between brain energy deficit and neurological dysfunction.
The Creatine Reference Problem in MRS
An interesting methodological issue in brain MRS research involves the use of total creatine (tCr = creatine + phosphocreatine) as an internal reference standard.
For decades, many MRS studies expressed metabolite concentrations as ratios to tCr (e.g., NAA/tCr, choline/tCr) based on the assumption that total brain creatine levels were stable and did not change across conditions.
However, research has revealed that this assumption is incorrect. Brain creatine levels change with:
- Diet (lower in vegetarians/vegans)
- Supplementation (increased with creatine supplementation)
- Age (declining with aging)
- Disease (altered in depression, TBI, neurodegenerative conditions)
- Creatine deficiency syndromes (dramatically reduced)
This means that studies using tCr as a reference may have inadvertently introduced errors, particularly when studying populations or conditions where brain creatine levels differ from normal.
Modern MRS studies increasingly use water-referenced or absolute quantification methods to avoid this issue.
What Brain Imaging Tells Us About Creatine’s Mechanism
Brain imaging studies provide crucial mechanistic evidence connecting oral creatine supplementation to cognitive enhancement:
1. Supplementation increases brain PCr reserves. MRS confirms that oral creatine reaches the brain and increases phosphocreatine stores.
2. Higher PCr correlates with better cognitive function. Studies correlating MRS metabolite levels with cognitive test scores support the link between brain energy status and cognitive performance.
3. Brain regions with highest metabolic demands show the greatest sensitivity to creatine status. The prefrontal cortex and hippocampus — regions essential for working memory, reasoning, and memory formation — are both highly metabolically active and sensitive to PCr availability.
4. Disease states show reduced brain creatine. Neuroimaging in conditions like depression and neurodegeneration consistently shows reduced brain creatine, providing a rationale for supplementation.
Wallimann et al. (2011) integrated the neuroimaging evidence with biochemical data to provide a thorough model of the creatine kinase/phosphocreatine energy system in the brain (Wallimann et al., 2011) .
Advanced Imaging Techniques
Beyond standard MRS, several advanced neuroimaging techniques are contributing to our understanding of brain creatine:
31P-MRS directly measures phosphocreatine and ATP, providing the most specific information about brain energy status. This technique has been used to detect changes in PCr/ATP ratios following creatine supplementation.
Chemical exchange saturation transfer (CEST) MRI is a newer technique that can map creatine distribution across the brain with higher spatial resolution than conventional MRS, revealing regional variations in brain creatine content.
Functional MRS combines metabolic measurement with cognitive task performance, allowing researchers to observe how brain creatine and phosphocreatine levels change in real time during cognitive tasks.
Malaysian Context
While advanced neuroimaging facilities are available at major Malaysian research hospitals (UMMC, Hospital Kuala Lumpur, USM), MRS for creatine research remains primarily a tool in international research settings.
However, the findings from global MRS studies directly inform Malaysian consumers about the value of creatine supplementation.
The ISSN position stand acknowledges the neuroimaging evidence as supportive of creatine’s cognitive benefits (Kreider et al., 2017) .
For Malaysian consumers, this means that the recommendation to supplement with 5g/day creatine monohydrate for cognitive benefits is backed by both clinical outcomes and objective neuroimaging data.
Creatine monohydrate is available throughout Malaysia via Shopee, Lazada, and local retailers, with halal-certified options from RM40.
For Malaysian Readers
- Where to buy creatine in Malaysia — local pricing, halal brands, Shopee/Lazada channels
- Creatine for Malaysian seniors — local context, demographic-specific guidance
Sources & References
This article draws on Wallimann et al. (2011), Rae et al. (2003), Avgerinos et al. (2018), Roschel et al. (2021), and the ISSN Position Stand (Kreider et al., 2017).
Full citations are available in our Research Library.